A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

D. Schuirmann

DOI:10.1007/BF01068419

Corpus ID: 206788664

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

@article{Schuirmann2005ACO,
  title={A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability},
  author={D. Schuirmann},
  journal={Journal of Pharmacokinetics and Biopharmaceutics},
  year={2005},
  volume={15},
  pages={657-680}
}

D. Schuirmann

Published 2005

Mathematics, Medicine

Journal of Pharmacokinetics and Biopharmaceutics

The statistical test of the hypothesis of no difference between the average bioavailabilities of two drug formulations, usually supplemented by an assessment of what the power of the statistical test would have been if the true averages had been inequivalent, continues to be used in the statistical analysis of bioavailability/bioequivalence studies. In the present article, this Power Approach (which in practice usually consists of testing the hypothesis of no difference at level 0.05 and… CONTINUE READING

View on Springer

Share This Paper

1,512 Citations

Highly Influential Citations

Background Citations

143

Methods Citations

484

Results Citations

Figures, Tables, and Topics from this paper

Figures and Tables

Paper Mentions

Interventional Clinical Trial

Impact of Early Post-Operative Water Exposure on Complications of Cutaneous Surgeries

Patients are often counseled to keep a surgical wound dry for 2 to 3 days. The rationale is likely to decrease the risk of infection and bleeding. However, this has never been formally… Expand

Conditions	Surgical Wound Infection
Intervention	Behavioral

Milton S. Hershey Medical Center

March 2013 - January 2020

Interventional Clinical Trial

A Study of Sofosbuvir and Ledipasvir From Soviredia 90/400 mg Tablets (Minapharm, Egypt) Versus Harvoni 90/400 mg Tablets (Gilead Sciences, USA)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir and Ledipasvir from… Expand

Conditions	Healthy
Intervention	Drug

Genuine Research Center, Egypt

April 2017 - May 2017

Interventional Clinical Trial

A Bio-equivalence Study of Sofosbuvir From Sofodelevier 400 mg Film Coated Tablets (Al-debeiky Pharma, Egypt) Versus Sovaldi 400 mg Tablets (Gilead Sciences, Canada)

Comparative randomized, single dose, three way three sequence two treatment partial replicate crossover open-label study to determine the bioequivalence of Sofosbuvir from Sofodelevier… Expand

Conditions	Healthy
Intervention	Drug

Genuine Research Center, Egypt

October 2016 - November 2016

Interventional Clinical Trial

Bioequivalence Study of Linagliptin From Prevaglip 5 mg Tablets(Eva Pharma, Egypt) and Trajenta 5 mg Tablets (Boehringer Ingelheim International GmbH, Germany)

An open label randomized, single dose, two-way crossover bioequivalence study to determine the bioequivalence of Linagliptin from Prevaglip 5 mg tablets(Eva pharma for Pharmaceuticals… Expand